share_log

国信证券股份有限公司关于申联生物医药(上海)股份有限公司使用部分闲置募集资金进行现金管理的核查意见

Guoxin Securities Co., Ltd. inspection opinions on the use of some idle funds raised by Shenlian Biopharmaceuticals (Shanghai) Co., Ltd. for cash management

SZSI ·  Oct 30, 2024 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more